Bracco, Guerbet Reportedly Targeting Bayer Radiology Business
By Sanjit Dutt Posted on 13 Dec 2016 |
Image: Bayer is considering the sale of its radiology supplies unit, with Bracco and Guerbet among the interested buyers (Photo courtesy of Bayer).
Italian healthcare group Bracco S.p.A. (Milan, Italy) is reportedly working on a potential bid for the radiology supplies unit of Bayer AG (Leverkusen, Germany).
Since May this year, there have been reports that Bayer might be willing to part with its USD 3 billion radiology supplies unit comprising of radiological contrast agents and injection equipment that earns revenues of more than USD 1.7 billion. Bayer’s Gadavist for MR scans and Ultravist for CT are among its most widely used contrast agents, raking in over USD 300 million in 2015.
Bracco is now reported to have entrusted an investment bank with the task of locating a partner for a possible joint offer for the unit valued at more than USD 4.3 billion. Meanwhile, Guerbet (Paris, France), a specialist in contrast agents and solutions for medical imaging, is apparently also in talks with potential partners to acquire Bayer’s radiology supplies business.
Bayer is yet to make a final decision on selling its radiology supplies unit. However, earlier this year, it had reportedly mandated Goldman Sachs (New York City, NY, USA) as a sell-side advisor and sent out information to prospective buyers. Bayer is also offering its radiology supplies business to interested private equity parties and the auction had been expected to start next year, according to reports.
Related Links:
Bracco
Bayer
Guerbet
Goldman Sachs
Since May this year, there have been reports that Bayer might be willing to part with its USD 3 billion radiology supplies unit comprising of radiological contrast agents and injection equipment that earns revenues of more than USD 1.7 billion. Bayer’s Gadavist for MR scans and Ultravist for CT are among its most widely used contrast agents, raking in over USD 300 million in 2015.
Bracco is now reported to have entrusted an investment bank with the task of locating a partner for a possible joint offer for the unit valued at more than USD 4.3 billion. Meanwhile, Guerbet (Paris, France), a specialist in contrast agents and solutions for medical imaging, is apparently also in talks with potential partners to acquire Bayer’s radiology supplies business.
Bayer is yet to make a final decision on selling its radiology supplies unit. However, earlier this year, it had reportedly mandated Goldman Sachs (New York City, NY, USA) as a sell-side advisor and sent out information to prospective buyers. Bayer is also offering its radiology supplies business to interested private equity parties and the auction had been expected to start next year, according to reports.
Related Links:
Bracco
Bayer
Guerbet
Goldman Sachs
Latest Industry News News
- Bayer and Google Partner on New AI Product for Radiologists
- Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement
- IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering
- International Societies Suggest Key Considerations for AI Radiology Tools
- Samsung's X-Ray Devices to Be Powered by Lunit AI Solutions for Advanced Chest Screening
- Canon Medical and Olympus Collaborate on Endoscopic Ultrasound Systems
- GE HealthCare Acquires AI Imaging Analysis Company MIM Software
- First Ever International Criteria Lays Foundation for Improved Diagnostic Imaging of Brain Tumors
- RSNA Unveils 10 Most Cited Radiology Studies of 2023
- RSNA 2023 Technical Exhibits to Offer Innovations in AI, 3D Printing and More
- AI Medical Imaging Products to Increase Five-Fold by 2035, Finds Study
- RSNA 2023 Technical Exhibits to Highlight Latest Medical Imaging Innovations
- AI-Powered Technologies to Aid Interpretation of X-Ray and MRI Images for Improved Disease Diagnosis
- Hologic and Bayer Partner to Improve Mammography Imaging
- Global Fixed and Mobile C-Arms Market Driven by Increasing Surgical Procedures
- Global Contrast Enhanced Ultrasound Market Driven by Demand for Early Detection of Chronic Diseases